An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
The presidential candidate of the African Democratic Congress, Atiku Abubakar, on Thursday hailed the Federal High Court in Abuja for striking out a suit challenging the leadership of the party, ...
With 1,059,360 registered voters set to decide Ekiti State’s next governor today, the All Progressives Congress, Peoples Democratic Party and African Democratic Congress have expressed confidence in ...
It’s been almost a decade since Japanese pharma company Daiichi Sankyo began its dramatic pivot from cardiovascular health into antibody-drug conjugates. For Daiichi Sankyo, it’s hard to argue that ...
According to Abdullahi, the submission of the candidates' details to the electoral body's portal underscores the party's determination to position itself as a viable alternative for Nigerians ahead of ...
The game is on for TROP2 antibody-drug conjugates in first-line triple-negative breast cancer. Less than a month after an approval for Daiichi Sankyo and AstraZeneca’s Datroway for front-line TNBC ...
Integrin β6 is expressed in ~90% of NSCLC and correlates with poor prognosis, supporting development of a selective, rapidly internalizing ADC designed to reduce off-target integrin binding.
Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antibodies with ...
Senator Garba Maidoki defected from the APC to the ADC, citing internal crises and injustice Maidoki believes the ADC is a better platform for his constituents and national development Deputy Senate ...
Hosted on MSN
NDC deregistration: ADC calls for united resistance against attempts to silence opposition
The African Democratic Congress (ADC) has condemned the Lokoja Federal High Court’s decision to set aside its earlier judgment recognising the Nigerian Democratic Congress (NDC). In a statement on ...
Salubris Biotechnology Co. have reported the development of novel antibody-drug conjugates (ADCs) against glypican-3 (GPC3), an oncofetal glycoprotein overexpressed in approximately 70%-85% of ...
AU, Switzerland & PRINCETON, N.J.--(BUSINESS WIRE)--Araris Biotech AG, a company advancing a differentiated pipeline of antibody-drug conjugates (“ADCs”) therapies, and Taiho Oncology, Inc., a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results